Home
|
Management
|
Contacts
|
Pharmacovigilance
|
Chiesi Group
SE
EN
Welcome to Chiesi
SVERIGE
Enter at least 3 characters
MENU
About us
Our company
Management
Our history
Chiesi globally
Compliance
Therapeutic areas
General
Respiratory
Neonatology
Rare diseases and special care
Order materials
Research and development
Pipeline
Production plants
Working at Chiesi
Career opportunities
Media
News and press release
This site uses cookies. Continuing to navigate is considered accepted usage.
More info
CLOSE
Respiratory
Asthma and COPD are the most common respiratory...
Respiratory
Asthma and COPD are the most common respiratory...
Neonatology
For decades, Chiesi has devoted themselves to the...
Neonatology
For decades, Chiesi has devoted themselves to the...
Rare diseases and special care
Chiesi invests in rare diseases and specialist...
Rare diseases and special care
Chiesi invests in rare diseases and specialist...
Order materials
Welcome to order information...
Order materials
Welcome to order information...
Chiesi Group Announces Establishment of New...
Chiesi outlines €350 million investment and...
PUBLICATIONS
2019
Annual Report 2018
Download
PDF
version
Other publications
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federation
Chiesi Pharmaceuticals LLC
Scandinavia
Chiesi Pharma AB
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.
Download PDF
